Order Article Reprints

Gómez-Fernández D, Romero-González A, Suárez-Rivero JM, Cilleros-Holgado P, Álvarez-Córdoba M, Piñero-Pérez R, Romero-Domínguez JM, Reche-López D, López-Cabrera A, Ibáñez-Mico S, et al. A Multi-Target Pharmacological Correction of a Lipoyltransferase LIPT1 Gene Mutation in Patient-Derived Cellular Models. Antioxidants. 2024; 13(8):1023. https://doi.org/10.3390/antiox13081023

Gómez-Fernández, David, Ana Romero-González, Juan M. Suárez-Rivero, Paula Cilleros-Holgado, Mónica Álvarez-Córdoba, Rocío Piñero-Pérez, José Manuel Romero-Domínguez, Diana Reche-López, Alejandra López-Cabrera, Salvador Ibáñez-Mico, and et al. 2024. "A Multi-Target Pharmacological Correction of a Lipoyltransferase LIPT1 Gene Mutation in Patient-Derived Cellular Models" Antioxidants 13, no. 8: 1023. https://doi.org/10.3390/antiox13081023

Gómez-Fernández, D., Romero-González, A., Suárez-Rivero, J. M., Cilleros-Holgado, P., Álvarez-Córdoba, M., Piñero-Pérez, R., Romero-Domínguez, J. M., Reche-López, D., López-Cabrera, A., Ibáñez-Mico, S., Castro de Oliveira, M., Rodríguez-Sacristán, A., González-Granero, S., García-Verdugo, J. M., & Sánchez-Alcázar, J. A. (2024). A Multi-Target Pharmacological Correction of a Lipoyltransferase LIPT1 Gene Mutation in Patient-Derived Cellular Models. Antioxidants, 13(8), 1023. https://doi.org/10.3390/antiox13081023